InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Mineralys Therapeutics, Inc.

MLYS Clue Score35
United States Fiscal year ends December CIK 0001933414 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

58
Insider
Date
Role
Action
Shares
Price
Amount
Eric Warren
21 Sep 2026
Chief Commercial Officer
Sold after exercise
7,438
$28.12
$209.14K
Daphne Karydas
15 Sep 2026
Director
Sold after exercise
3,000
$28.58
$85.74K
Eric Warren
21 Aug 2026
Chief Commercial Officer
Sold after exercise
7,437
$25.98
$193.19K
David Malcom Rodman
10 Aug 2026
Chief Medical Officer
Sold after exercise
2,170
$27.09
$58.79K
Eric Warren
21 Jul 2026
Chief Commercial Officer
Sold after exercise
7,438
$26.87
$199.89K
David Malcom Rodman
17 Jul 2026
Chief Medical Officer
Sold after exercise
416
$26.53
$11.04K
David Malcom Rodman
13 Jul 2026
Chief Medical Officer
Sold after exercise
14,058
$27.58
$387.72K
David Malcom Rodman
9 Jul 2026
Chief Medical Officer
Sold after exercise
2,171
$30.30
$65.78K
Eric Warren
26 Jun 2026
Chief Commercial Officer
Sold after exercise
104,124
$25.90
$2.70M
Daphne Karydas
17 Jun 2026
Director
Sold after exercise
3,000
$25.00
$75.00K
David Malcom Rodman
17 Jun 2026
Chief Medical Officer
Sold after exercise
4,584
$25.00
$114.60K
David Malcom Rodman
15 Jun 2026
Chief Medical Officer
Sold after exercise
9,890
$23.81
$235.49K
David Malcom Rodman
12 Jun 2026
Chief Medical Officer
Sold after exercise
6,349
$23.93
$151.90K
David Malcom Rodman
10 Jun 2026
Chief Medical Officer
Sold after exercise
2,170
$25.00
$54.25K
David Malcom Rodman
18 May 2026
Chief Medical Officer
Sold after exercise
417
$27.55
$11.49K
David Malcom Rodman
13 May 2026
Chief Medical Officer
Sold after exercise
14,056
$28.58
$401.79K
David Malcom Rodman
12 May 2026
Chief Medical Officer
Sold after exercise
6,348
$29.36
$186.35K
David Malcom Rodman
11 May 2026
Chief Medical Officer
Sold after exercise
2,171
$29.71
$64.50K
David Malcom Rodman
17 Apr 2026
Chief Medical Officer
Sold after exercise
416
$31.33
$13.03K
David Malcom Rodman
13 Apr 2026
Chief Medical Officer
Sold after exercise
14,058
$26.54
$373.09K
David Malcom Rodman
9 Apr 2026
Chief Medical Officer
Sold after exercise
2,170
$27.38
$59.41K
Daphne Karydas
31 Mar 2026
Director
Sold after exercise
3,000
$25.00
$75.00K
David Malcom Rodman
17 Mar 2026
Chief Medical Officer
Sold after exercise
417
$25.65
$10.70K
David Malcom Rodman
13 Mar 2026
Chief Medical Officer
Sold after exercise
253
$27.82
$7.04K
David Malcom Rodman
13 Mar 2026
Chief Medical Officer
Sold after exercise
3,079
$27.37
$84.26K
David Malcom Rodman
13 Mar 2026
Chief Medical Officer
Sold after exercise
10,726
$25.91
$277.92K
David Malcom Rodman
12 Mar 2026
Chief Medical Officer
Sold after exercise
6,348
$27.37
$173.75K
David Malcom Rodman
9 Mar 2026
Chief Medical Officer
Sold after exercise
2,171
$26.84
$58.27K
David Malcom Rodman
17 Feb 2026
Chief Medical Officer
Sold after exercise
417
$27.59
$11.51K
David Malcom Rodman
13 Feb 2026
Chief Medical Officer
Sold after exercise
6,348
$27.58
$175.10K
David Malcom Rodman
13 Feb 2026
Chief Medical Officer
Sold after exercise
4,166
$27.33
$113.86K
David Malcom Rodman
13 Feb 2026
Chief Medical Officer
Sold after exercise
3,541
$27.33
$96.78K
David Malcom Rodman
12 Feb 2026
Chief Medical Officer
Sold after exercise
521
$29.64
$15.44K
David Malcom Rodman
12 Feb 2026
Chief Medical Officer
Sold after exercise
5,828
$28.94
$168.63K
David Malcom Rodman
9 Feb 2026
Chief Medical Officer
Sold after exercise
2,171
$30.21
$65.59K
David Malcom Rodman
20 Jan 2026
Chief Medical Officer
Sold after exercise
416
$32.10
$13.35K
David Malcom Rodman
13 Jan 2026
Chief Medical Officer
Sold after exercise
7,709
$32.75
$252.47K
David Malcom Rodman
12 Jan 2026
Chief Medical Officer
Sold after exercise
6,348
$32.32
$205.14K
David Malcom Rodman
9 Jan 2026
Chief Medical Officer
Sold after exercise
2,170
$33.27
$72.20K
David Malcom Rodman
5 Jan 2026
Chief Medical Officer
Sold after exercise
53,470
$35.53
$1.90M
David Malcom Rodman
5 Jan 2026
Chief Medical Officer
Sold after exercise
139,245
$34.83
$4.85M
David Malcom Rodman
2 Jan 2026
Chief Medical Officer
Sold after exercise
70,037
$35.87
$2.51M
Alexander M Gold
13 Nov 2025
Director
Sold after exercise
12,742
$46.50
$592.50K
Daphne Karydas
13 Nov 2025
Director
Sold after exercise
4,885
$46.36
$226.45K
Daphne Karydas
13 Nov 2025
Director
Sold after exercise
10,115
$45.81
$463.35K
Alexander M Gold
12 Nov 2025
Director
Sold after exercise
1,933
$47.28
$91.39K
Alexander M Gold
12 Nov 2025
Director
Sold after exercise
5,000
$46.50
$232.50K
Alexander M Gold
11 Nov 2025
Director
Sold after exercise
5,000
$47.08
$235.41K
Alexander M Gold
11 Nov 2025
Director
Sold after exercise
10,000
$42.43
$424.30K
Adam Scott Levy
11 Nov 2025
CFO and Secretary
Sold after exercise
32,718
$46.88
$1.53M
Adam Scott Levy
11 Nov 2025
CFO and Secretary
Sold after exercise
38,900
$45.93
$1.79M
Adam Scott Levy
11 Nov 2025
CFO and Secretary
Sold after exercise
8,456
$45.18
$382.05K
Adam Scott Levy
11 Nov 2025
CFO and Secretary
Sold after exercise
4,142
$43.50
$180.18K
Adam Scott Levy
11 Nov 2025
CFO and Secretary
Sold after exercise
8,485
$42.34
$359.26K
Adam Scott Levy
11 Nov 2025
CFO and Secretary
Sold after exercise
12,952
$41.65
$539.48K
Adam Scott Levy
11 Nov 2025
CFO and Secretary
Sold after exercise
1,561
$42.68
$66.62K
Adam Scott Levy
11 Nov 2025
CFO and Secretary
Sold after exercise
11,295
$41.87
$472.93K
Adam Scott Levy
11 Nov 2025
CFO and Secretary
Sold after exercise
1,015
$42.00
$42.63K
Show all 83 transactions →

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 58
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 1,088,447
History held since 13 Feb 2023